Yang et al. introduced CD44 as a tumor-initiating cell (TIC) with CD90, and CD44s was observed to be the most frequent TIC marker occurring with other frequent markers including CD24, CD34, CD90, CD133, ALDH, and EpCAM [18]. This evidence concerns the gene THY1 and neoplasm.